1. Gupta, S, Steinmeyer, C, Frank, B, et al. Hyperglycemia and hypertriglyceridemia in real world patients on antipsychotic therapy. Am J Ther. 2003;10:348-355.
Google Scholar | Crossref | Medline2. Prasuna, PL, Sagar, KJV, Sudhakar, TP, Rao, GP. A placebo controlled trial on add-on modafinil on the anti-psychotic treatment emergent hyperglycemia and hyperlipidemia. Indian J Psychol Med. 2014;36:158-163.
Google Scholar | SAGE Journals3. Abosi, O, Lopes, S, Schmitz, S, Fiedorowicz, JG. Cardiometabolic effects of psychotropic medications. Horm Mol Biol Clin Investig. 2018;36:/j/hmbci.2018.36.issue-1/hmbci-2017-0065/hmbci-2017-0065.xml.
Google Scholar | Crossref | Medline4. Olfson, M, Marcus, SC, Corey-Lisle, P, Tuomari, AV, Hines, P, L’Italien, GJ. Hyperlipidemia following treatment with antipsychotic medications. Am J Psychiatry. 2006;163:1821-1825.
Google Scholar | Crossref | Medline5. Oliver, K, Suzana, U, Miro, J. Metabolic Syndrome in patients with psychotic disorders: diagnostic issues, comorbidity and side effects of anti-psychotics. Psychiatr Danub 2010;22:76-86.
Google Scholar6. Schroeder, M, Perez, E, Lares, M, et al. A review: association of preventable medical conditions, healthy nutrition, the ingestion of psychotropic medication and people who suffer from severe mental illnesses. Archivos Venezolanos de Farmacología y Terapéutica. 2010;29:20-25.
Google Scholar7. Vik-Mo, AO, Birkenaes, AB, Ferno, J, Jonsdottir, H, Andreassen, OA, Steen, VM. Increased expression of lipid biosynthesis genes in peripheral blood cells of olanzapine-treated patients. Int J Neuropsychopharmacol. 2008;11:679-684.
Google Scholar | Crossref | Medline8. Teff, KL, Kim, SF. Atypical antipsychotics and the neural regulation of food intake and peripheral metabolism. Physiol Behav. 2011;104:590-598.
Google Scholar | Crossref | Medline9. Ezzaher, A, Mouhamed, DH, Mechri, A, et al. Thyroid function and lipid profile in bipolar I patients. Asian J Psychiatr. 2011;4:139-143.
Google Scholar | Crossref | Medline10. Manu, P, Correll, CU, Wampers, M, et al. Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidone. Schizophr Res. 2013;143:358-362.
Google Scholar | Crossref | Medline | ISI11. Sugai, T, Suzuki, Y, Fukui, N, et al. Dysregulation of adipocytokines related to second-generation antipsychotics in normal fasting glucose patients with schizophrenia. J Clin Psychopharmacol. 2012;32:390-393.
Google Scholar | Crossref | Medline12. Wampers, M, Hanssens, L, van Winkel, R, et al. Differential effects of olanzapine and risperidone on plasma adiponectin levels over time: results from a 3-month prospective open-label study. Eur Neuropsychopharmacol. 2012;22:17-26.
Google Scholar | Crossref | Medline13. Jarcho, JA, Keaney, JF Proof that lower is better-LDL cholesterol and improve-it. N Engl J Med. 2015;372:2448-2450.
Google Scholar | Crossref | Medline | ISI14. World Health Organization . Quantifying selected major risks to health. In: The World Health Reports 2002-Reducing Risks, Promoting Health Life. World Health Organization; 2002:47-97.
Google Scholar15. Stamler, J, Daviglus, ML, Garside, DB, Dyer, AR, Greenland, P, Neaton, JD. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA. 2000;284:311-318.
Google Scholar | Crossref | Medline | ISI16. Grundy, SM, Cleeman, JI, Merz, CNB, et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation. 2004;110:227-239.
Google Scholar | Crossref | Medline | ISI17. Vancampfort, D, Probst, M, Knapen, J, Carraro, A, De Hert, M. Associations between sedentary behaviour and metabolic parameters in patients with schizophrenia. Psychiatry Res. 2012;200:73-78.
Google Scholar | Crossref | Medline | ISI18. Asaye, S, Bekele, S, Tolessa, D, Cheneke, W. Metabolic syndrome and associated factors among psychiatric patients in Jimma University Specialized Hospital, South West Ethiopia. Diabetes Metab Syndr. 2018;12:753-760.
Google Scholar | Crossref | Medline19. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults . Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285:2486-2497.
Google Scholar | Crossref | Medline | ISI20. Carey, RM, Whelton, PK. Prevention, detection, evaluation, and management of high blood pressure in adults: synopsis of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline. Ann Intern Med. 2018;168:351-358.
Google Scholar | Crossref21. Severe mental illness defined by duration and disability . Accessed April 7, 2021. http://www.bhevolution.org/public/severe_mental_illness.page
Google Scholar22. World Health Organization (WHO) . Chronic diseases and health promotion: stepwise approach to surveillance (STEPS). 2010. https://www.who.int/ncds/surveillance/steps/manual/en/
Google Scholar23. Ko, YK, Soh, MA, Kang, SH, Lee, J-I. The prevalence of metabolic syndrome in schizophrenic patients using antipsychotics. Clin Psychopharmacol Neurosci. 2013;11:80-88.
Google Scholar | Crossref | Medline24. John, S, Dharwadkar, K, Motagi, MV. Study on association between lipid profile values and psychiatric disorders. J Clin Diagn Res. 2014;8:WC04-WC06.
Google Scholar25. Sweileh, WM, Sa’ed, HZ, Dalal, SA, Ibwini, S, Sawalha, AF, Ali, I. Prevalence of metabolic syndrome among patients with schizophrenia in Palestine. BMC Psychiatry. 2012;12:235.
Google Scholar | Crossref | Medline26. Kim, SH, Kim, K, Kwak, MH, Kim, HJ, Kim, HS, Han, KH. The contribution of abdominal obesity and dyslipidemia to metabolic syndrome in psychiatric patients. Korean J Intern Med. 2010;25:168-173.
Google Scholar | Crossref | Medline27. Saloojee, S, Burns, JK, Motala, AA. Metabolic syndrome in South African patients with severe mental illness: prevalence and associated risk factors. PLoS One. 2016;11:e0149209.
Google Scholar | Crossref | Medline28. Mousa, FA, Dessoki, HH, El Kateb, SM, Ezzat, AA, Soltan, MR. Metabolic syndrome in psychiatric patients (comparative study). Egypt J Psychiatry. 2017; 38:179.
Google Scholar | Crossref29. Çankaya, PK, Tiryaki, A, Arslan, FC, Cankaya, S. Comparison of the prevalence of metabolic syndrome in patients with schizophrenia and bipolar disorder: a cross-sectional study from Black Sea region. Am J Psychiatry. 2018;19: 346-354.
Google Scholar30. Alosaimi, FD, Abalhassan, M, Alhaddad, B, et al. Prevalence of metabolic syndrome and its components among patients with various psychiatric diagnoses and treatments: a cross-sectional study. Gen Hosp Psychiatry. 2017;45:62-69.
Google Scholar | Crossref | Medline31. Seow, LS, Chong, SA, Wang, P, Shafie, S, Ong, HL, Subramaniam, M. Metabolic syndrome and cardiovascular risk among institutionalized patients with schizophrenia receiving long term tertiary care. Compr Psychiatry. 2017;74:196-203.
Google Scholar | Crossref | Medline32. Bressington, DT, Mui, J, Cheung, EF, Petch, J, Clark, AB, Gray, R. The prevalence of metabolic syndrome amongst patients with severe mental illness in the community in Hong Kong. a cross sectional study. BMC Psychiatry. 2013;13:87.
Google Scholar | Crossref | Medline | ISI33. Maaroganye, K, Mohapi, M, Krüger, C, Rheeder, P. The prevalence of metabolic syndrome and its associated factors in long-term patients in a specialist psychiatric hospital in South Africa. Afr J Psychiatry. 2013;16:(6).
Google Scholar34. Tadewos, A, Zelalem, A, Ambachew, H, Banerjee, S. Prevalence of dyslipidemia among HIV-infected patients using first-line highly active antiretroviral therapy in Southern Ethiopia: a cross-sectional comparative group study. AIDS Res Ther. 2012;9:31.
Google Scholar | Crossref | Medline | ISI35. Hirigo, AT, Geleta, EN. Factors associated with atherogenic dyslipidemia among hypertensive patients at southern Ethiopia. Int J Med Med Sci. 2018;10:86-93.
Google Scholar | Crossref36. Takata, K, Imaizumi, S, Kawachi, E, et al. Impact of cigarette smoking cessation on high-density lipoprotein functionality. Circ J. 2014;78:2955-2962.
Google Scholar | Crossref | Medline37. Xu, T, Holzapfel, C, Dong, X, et al. Effects of smoking and smoking cessation on human serum metabolite profile: results from the KORA cohort study. BMC Med. 2013;11:60.
Google Scholar | Crossref | Medline38. BenowitzNL. Drug therapy . Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med. 1988;319:1318-1330.
Google Scholar | Crossref | Medline39. Gebreyes, YF, Goshu, DY, Geletew, TK, et al. Prevalence of high bloodpressure, hyperglycemia, dyslipidemia, metabolic syndrome and their determinants in Ethiopia: evidences from the National NCDs STEPS Survey, 2015. PLoS One. 2018;13:e0194819.
Google Scholar | Crossref